News
Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...
1don MSN
Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...
19h
GlobalData on MSNNovo Nordisk defeated in Wegovy patent dispute by ViatrisThe Delaware court ruled that Viatris’ drug does not infringe the "administered without another therapeutic agent" limitation ...
What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...
After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic versions of Novo Nordisk’s lucrative semaglutide drugs for diabetes and obesi | ...
14h
Verywell Health on MSNWhat Happens to Your Body When You Stop Taking OzempicMany people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to know before stopping.
People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...
Initially, Dr Reddy's will focus on launching the generic semaglutide in Canada, India, Brazil, Turkey, and other emerging ...
The company initially plans to launch the generic version in Canada, India, Brazil, Turkey and other emerging markets, ...
Wales Online on MSN1h
Weight-loss jabs could help obese people control asthma, study saysWeight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a ...
A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...
6d
Zacks.com on MSNCan Wegovy & Ozempic Drive Another Strong Quarter for Novo Nordisk?Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results